Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/20/2012CA2828518A1 Pyridinyl- and pyrazinyl-methyloxy-aryl derivatives useful as inhibitors of spleen tyrosine kinase (syk)
09/20/2012CA2828378A1 Nitrogen-containing saturated heterocyclic compound
09/20/2012CA2828043A1 Overcoming resistance to erbb pathway inhibitors
09/20/2012CA2827629A1 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these
09/20/2012CA2827161A1 6,5-heterocyclic propargylic alcohol compounds and uses therefor
09/20/2012CA2826678A1 Sulfonamide compounds having trpm8 antagonistic activity
09/19/2012EP2500430A2 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
09/19/2012EP2500429A2 RNAi for the control of insects and arachnids
09/19/2012EP2500349A1 Synthetic LTA mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections
09/19/2012EP2500347A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
09/19/2012EP2500345A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
09/19/2012EP2500344A1 Aminothiazine or aminooxazine derivative having amino linker
09/19/2012EP2500339A1 Crystalline forms of pitavastatin calcium
09/19/2012EP2500337A2 Solid form comprising (-) o-desmethylvenlafaxine and uses thereof
09/19/2012EP2500063A1 Combination therapy using HDAC inhibitors and melphalan for treating cancer
09/19/2012EP2500062A2 C-19 steroids for specific therapeutic uses
09/19/2012EP2500038A1 Pharmaceutical composition for external use
09/19/2012EP2500025A1 Oligo-guluronate and galacturonate compositions
09/19/2012EP2500024A1 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine
09/19/2012EP2500023A1 Antibiotics composition comprising beta-lactam antibiotic, beta-lactamase inhibitor, and buffer component
09/19/2012EP2500022A1 Antibacterial agent for drug-resistant bacteria, method for screening for same, and use of same
09/19/2012EP2500021A1 Therapeutic uses of VX-950
09/19/2012EP2500020A1 Therapeutic or prophylactic agent for diabetes
09/19/2012EP2500019A1 Modifying pirfenidone treatment for patients with atypical liver function
09/19/2012EP2500018A1 Preventing and/or Treating Cardiovascular Disease and/or Associated Heart Failure
09/19/2012EP2500017A1 Use of ketogenic compounds for treatment of age-associated memory impairment
09/19/2012EP2500016A1 Doxylamine resinate complex
09/19/2012EP2500013A1 Pharmaceutical composition comprising solifenacin
09/19/2012EP2499915A1 Virus-inactivating agent
09/19/2012EP2499914A1 Antiseptic solutions comprising chlorhexidine or its salt and an anionic dye and their preparation
09/19/2012EP2499913A1 Antiseptic solutions comprising chlorhexidine or its salt and an anionic dye and their preparation
09/19/2012EP2499497A1 Human fertility test using dpy19l2
09/19/2012EP2499263A2 Markers associated with ribavirin-induced anemia
09/19/2012EP2499249A1 Antisense molecules and methods for treating pathologies
09/19/2012EP2499248A1 Antisense antiviral compound and method for treating influenza viral infection
09/19/2012EP2499247A2 Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity
09/19/2012EP2499151A2 Mammalian metabolites of steroids
09/19/2012EP2499150A1 Novel mannopyranoside derivatives with anticancer activity
09/19/2012EP2499149A2 Process for preparing ruthenium(0)-olefin complexes
09/19/2012EP2499148A2 Conformationally constrained, fully synthetic macrocyclic compounds
09/19/2012EP2499146A1 Tricyclic pyrazol amine derivatives
09/19/2012EP2499145A2 Spiro-oxindole mdm2 antagonists
09/19/2012EP2499144A1 Quinoline and quinoxaline derivatives as kinase inhibitors
09/19/2012EP2499143A1 N-7 substituted purine and pyrazolopyrimidine compounds, compositions and methods of use
09/19/2012EP2499142A1 Substituted fused pyrimidine compounds, its preparation and uses thereof
09/19/2012EP2499141A2 Polymorphs of nevirapine and method for increasing the solubility of a transcriptase inhibitor composition
09/19/2012EP2499140A1 N2-pyrazolospiroketone acetyl-coa carboxylase inhibitors
09/19/2012EP2499139A1 N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
09/19/2012EP2499138A1 Propane-i-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof
09/19/2012EP2499137A1 Palonosetron metabolites
09/19/2012EP2499135A1 Androgen receptor modulator and uses thereof
09/19/2012EP2499132A1 Hepatitis c virus inhibitors
09/19/2012EP2499129A1 Quinoline and quinoxaline derivatives as kinase inhibitors
09/19/2012EP2499128A1 Crystalline cdc7 inhibitor salts
09/19/2012EP2499127A1 Hepatitis c virus inhibitors
09/19/2012EP2499126A1 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
09/19/2012EP2499124A1 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof
09/19/2012EP2499123A1 Anti-inflammatory compounds
09/19/2012EP2499121A1 Oxazoline derivatives for treatment of cns disorders.
09/19/2012EP2499120A1 Novel 1,3-oxazolidine compounds and their use as renin inhibitors
09/19/2012EP2499117A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
09/19/2012EP2499116A1 Sorafenib ethylsulfonate salt, process for preparation and use
09/19/2012EP2499114A1 Compounds inhibitors of enzyme lactate dehydrogenase (ldh) and pharmaceutical compositions containing these compounds
09/19/2012EP2499113A1 Homoglutamic acid derivatives
09/19/2012EP2499112A1 Substituted 3-(phenoxymethyl) benzyl amines and personal care compositions
09/19/2012EP2498818A2 Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
09/19/2012EP2498795A2 Granulysin in immunotherapy
09/19/2012EP2498793A1 Use of peptide epoxyketones for metastasis suppression
09/19/2012EP2498792A1 Methods and compositions for rapid treatment of otitis externa
09/19/2012EP2498785A1 Use of synergistic combinations of an avermectin and an antineoplastic compounds for the treatment of hematological malignancies
09/19/2012EP2498783A2 Compositions and methods for stimulating hair growth
09/19/2012EP2498782A1 Crystalline forms of neurotrophin mimetic compounds and their salts
09/19/2012EP2498781A2 Aryl and heteroaryl sulfones as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
09/19/2012EP2498780A2 N-9-substituted purine compounds, compositions and methods of use
09/19/2012EP2498779A1 Pemirolast for the treatment of systemic low grade inflammation
09/19/2012EP2498778A1 Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
09/19/2012EP2498777A2 Drug combination with theobromine and its use in therapy
09/19/2012EP2498776A1 Drug combination with theobromine and its use in therapy
09/19/2012EP2498775A1 New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2h)-one derivatives
09/19/2012EP2498774A1 Dual-action compounds targeting adenosine a2a receptor and adenosine transporter for prevention and treatment of neurodegenerative diseases
09/19/2012EP2498773A2 Compositions for the treatment of chemoresistant leukaemia and/or of potentially chemoresistant leukaemia
09/19/2012EP2498772A2 Composition and methods for improving skin appearance
09/19/2012EP2498771A1 Use of bethanechol for treatment of xerostomia
09/19/2012EP2498770A2 Pharmaceutical composition
09/19/2012EP2498769A1 Method of treatment and screening method
09/19/2012EP2498768A1 Pharmaceutical combination of prostaglandin compound and nsaid for the treatment of glaucoma and ocular hypertension
09/19/2012EP2498767A1 Treatment of microbial infections
09/19/2012EP2498766A1 Polymeric or oligomeric active ingredients having a biocidal effect, method for the production thereof, and composition comprising a polymeric or oligomeric active ingredient
09/19/2012EP2498765A1 Use of lutein containing compositions to improve certain aspects of memory
09/19/2012EP2498762A2 Method for preventing the crystallisation of pharmaceuticals in a polymer film
09/19/2012EP2498760A1 Delivery carrier
09/19/2012EP2498759A2 Immediate release tablet formulations
09/19/2012EP2498757A1 Reduced mass metformin formulations
09/19/2012EP2498756A1 Tablet formulations of neratinib maleate
09/19/2012EP2498755A1 Dynamic thermoresponsive nanoparticles for stabilization of enzymes at high temperatures
09/19/2012EP2498753A2 Nanosuspension of a poorly soluble drug made by microfluidization process
09/19/2012EP2498751A2 Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
09/19/2012EP2498749A1 Polysaccharide gel formulation having multi-stage bioactive agent delivery
09/19/2012EP2498731A2 Methods of treating or preventing stent thrombosis
09/19/2012EP2498611A1 Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
1 ... 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 ... 7860